NA
Nicholas A.J. Botwood sold $1.2M of SNDX stock
Nicholas A.J. Botwood, Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX), sold 65,515 shares of SNDX stock worth $1.2M, per an SEC Form 4 filed Jun 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 11, 2026, 1 day before it was made public.
SNDX has moved -46.7% since the trade date, from $17.91 to $9.55 (Nov 9, 2026 close).
- Traded
- Jun 11, 2026
- Disclosed
- Jun 12, 2026
- Filing delay
- 1 day
- Price since
- -46.7%
- Role
- Head of R&D, CMO
- Source
- SEC Form 4